Clinical Trial Update: Randomized Controlled Trial of Silymarin in Asthma [Phase 2, Phase 3]

View source ↗

Summary

A randomized controlled trial of silymarin for atopic asthma was withdrawn (Phase 2/Phase 3) according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Asthma

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Vanderbilt University | Conditions: Atopic Asthma | Phase 2, Phase 3 | Status: WITHDRAWN